Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehul Patel

Showing results (141-150 of 202) with videos related to

Pageof 21
Sort By:
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 24, 2025
A Randomized, Double-Blind Crossover Study of Change in Post-Dose Lung Function with Hydrofluoroolefin-1234ze, a Next-Generation Propellant for Metered Dose Inhalers, in Participants with AsthmaRoy A Pleasants, Alan S Bell, Mandeep Jassal, et al.
Chemistry & Biodiversity|April 16, 2024
Computational Exploration of Naturally Occurring Flavonoids as TGF-β Inhibitors in Breast Cancer: Insights from Docking and Molecular Dynamics Simulations and In-vitro Cytotoxicity StudyUmang Shah, Niyati Patel, Mehul Patel, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 27, 2021
Role of Natural and Synthetic Flavonoids as Potential Aromatase Inhibitors in Breast Cancer: Structure-Activity Relationship PerspectiveUmang Shah, Aarti Patel, Samir Patel, et al.
ERJ Open Research|December 17, 2025
Short-acting β<sub>2</sub>-agonist use, exacerbation risk and triple therapy in COPD: <i>post hoc</i> analyses of ETHOSJohn R Hurst, Dave Singh, Fernando J Martinez, et al.
American Journal of Surgery|February 24, 2006
A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrenceSukamal Saha, Rajesh Sehgal, Rajesh Seghal, et al.
Clinical Therapeutics|December 4, 2025
Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a SpacerHitesh Pandya, Mehul Patel, Michael Gillen, et al.
Leukemia & Lymphoma|October 18, 2012
Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort studyBrian J Minnema, Shahid Husain, Tony Mazzulli, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 10, 2019
The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factorsWolfgang Fleischhacker, Silvana Galderisi, István Laszlovszky, et al.
JACC. Cardiovascular Interventions|August 21, 2010
Outcomes of patients discharged the same day following percutaneous coronary interventionMehul Patel, Michael Kim, Rucha Karajgikar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 18, 2024
Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOSShigeo Muro, Munehiro Seki, John R Hurst, et al.
Pageof 21

Showing results (141-150 of 202) with videos related to

Sort By:
Pageof 21
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 24, 2025
A Randomized, Double-Blind Crossover Study of Change in Post-Dose Lung Function with Hydrofluoroolefin-1234ze, a Next-Generation Propellant for Metered Dose Inhalers, in Participants with AsthmaRoy A Pleasants, Alan S Bell, Mandeep Jassal, et al.
Chemistry & Biodiversity|April 16, 2024
Computational Exploration of Naturally Occurring Flavonoids as TGF-β Inhibitors in Breast Cancer: Insights from Docking and Molecular Dynamics Simulations and In-vitro Cytotoxicity StudyUmang Shah, Niyati Patel, Mehul Patel, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 27, 2021
Role of Natural and Synthetic Flavonoids as Potential Aromatase Inhibitors in Breast Cancer: Structure-Activity Relationship PerspectiveUmang Shah, Aarti Patel, Samir Patel, et al.
ERJ Open Research|December 17, 2025
Short-acting β<sub>2</sub>-agonist use, exacerbation risk and triple therapy in COPD: <i>post hoc</i> analyses of ETHOSJohn R Hurst, Dave Singh, Fernando J Martinez, et al.
American Journal of Surgery|February 24, 2006
A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrenceSukamal Saha, Rajesh Sehgal, Rajesh Seghal, et al.
Clinical Therapeutics|December 4, 2025
Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a SpacerHitesh Pandya, Mehul Patel, Michael Gillen, et al.
Leukemia & Lymphoma|October 18, 2012
Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort studyBrian J Minnema, Shahid Husain, Tony Mazzulli, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 10, 2019
The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factorsWolfgang Fleischhacker, Silvana Galderisi, István Laszlovszky, et al.
JACC. Cardiovascular Interventions|August 21, 2010
Outcomes of patients discharged the same day following percutaneous coronary interventionMehul Patel, Michael Kim, Rucha Karajgikar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 18, 2024
Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOSShigeo Muro, Munehiro Seki, John R Hurst, et al.
Pageof 21